Special Issue "Nanotechnology in Vaccine"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (15 January 2020) | Viewed by 7619
Special Issue Editor

Interests: plasmonic nanomaterials; quantum dots; graphene oxide; SERS
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has a huge impact on the whole of technology, and its applications are truly infinite. In the near future, among the various fields, one of the most beneficial areas of nanotechnology to mankind will be the vaccine field that can be directly related to our lives. Although many developments have been made in the vaccine area so far, many of the existing vaccines have disadvantages and no effective vaccines have been produced for some diseases. Since the development of novel and effective vaccines is still a very important issue, recently many researchers have been using nanotechnology as a powerful tool for solving the problems of current vaccines and proved that nanotechnology-based vaccines are more efficient than conventional vaccines. Since nanotechnology might hold promise in vaccines, this Special Issue is aimed to provide a range of original contributions of nanotechnology in vaccines.
Prof. Bong-Hyun Jun
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- vaccine
- nanovaccines
- vaccination
- nanomedicine